Clinical Trial Update: Study of Quinvaxem for Vaccination Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by Haemophilus Influenzae Type B [Phase 3]

View source ↗

Summary

Phase 3 results for Quinvaxem, a pentavalent vaccine against diphtheria, pertussis, tetanus, hepatitis B, and Haemophilus influenzae type B, were completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Infection
• Hepatitis B
• Pertussis
• Tetanus

Drugs mentioned

• Quinvaxem (Diphtheria-tetanus-pertussis-hepatitis B-Haemophilus influenzae type b conjugate vaccine)

Snippet

Sponsor: Crucell Holland BV | Conditions: Diphtheria, Pertussis | Phase 3 | Status: COMPLETED | Results posted: 2013-06-24